ChitogenX Inc.
CHNXF · OTC
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.01 | 0.10 | 0.09 |
| FCF Yield | 5.98% | -1.57% | -1.80% | -1.29% |
| EV / EBITDA | -12.53 | -48.36 | 575.34 | -14.96 |
| Quality | ||||
| ROIC | 12.08% | 8.16% | 4.83% | 34.74% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.06 | 0.08 | 0.46 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 244.00% | 65.75% | 19.78% | 69.15% |
| Safety | ||||
| Net Debt / EBITDA | -10.96 | -34.88 | 285.43 | -5.28 |
| Interest Coverage | -1.76 | -1.05 | -0.63 | -4.06 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -23,490.00 | -21,910.00 |